JFK promotes ING4 degradation through an SCF-dependent pathway. (A) Wild-type JFK promotes ING4 degradation in breast cancer cell lines. MCF-7 and MDA-MB-231 cells were transfected with empty vector or Flag-tagged JFK or treated with control siRNA or JFK siRNA. Cellular extracts were prepared, and Western blotting was performed with the antibodies against the indicated proteins. (B) Wild-type JFK, but not JFK mutants, promotes ING4 degradation. MCF-7 cells were transfected with Flag-tagged JFK, JFKΔF-box, or JFKΔKelch. Cellular extracts were prepared, and Western blotting was performed with the antibodies against the indicated proteins. (C) JFK negatively affects the steady-state level of the ING4 protein. MCF-7 cells were transfected with increasing amounts of Flag-JFK. Forty-eight hours after transfection, cells were treated with DMSO or MG132 for 6 h before cells were collected for Western blotting analysis. (D) The destruction of ING4 by JFK is mediated by an SCF complex. MCF-7 cells were transfected with Flag-JFK and treated with siRNAs for Cul1, Skp1, or Cdc20 as indicated. Cellular proteins were extracted for Western blotting analysis with antibodies against the indicated proteins, or total RNAs were extracted and analyzed for ING4 expression by real-time RT–PCR. Bars represent the mean ± SD for triplicate experiments. (E) JFK negatively regulates ING4 half-life. MCF-7 cells were transfected with empty vector or Flag-JFK or treated with control siRNA or JFK siRNA. Forty-eight hours after transfection, cells were treated with 50 μg/mL cycloheximide (CHX) for the indicated times in the presence or absence of MG132 before cellular proteins were extracted for Western blotting analysis. Quantitation was done by densitometry and expressed as signals of ING4/β-actin. Bars represent the mean ± SD for triplicate experiments. (F) JFK siRNA is specific. MCF-7 cells were transfected with vector or a JFK siRNA-1-resistant form (rJFK) together with control siRNA or JFK siRNA. Cellular proteins were extracted for Western blotting analysis with antibodies against the indicated proteins.